VOXVOKA Trademark

Trademark Overview

On Thursday, October 28, 2021, a trademark application was filed for VOXVOKA with the United States Patent and Trademark Office. The USPTO has given the VOXVOKA trademark a serial number of 97096624. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, October 25, 2024. This trademark is owned by Vertex Pharmaceuticals Incorporated. The VOXVOKA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations for the treatment of thalassemia and sickle cell disease
voxvoka

General Information

Serial Number97096624
Word MarkVOXVOKA
Filing DateThursday, October 28, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, October 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 20, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations for the treatment of thalassemia and sickle cell disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 9, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVertex Pharmaceuticals Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameVertex Pharmaceuticals Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events

Event DateEvent Description
Monday, November 1, 2021NEW APPLICATION ENTERED
Tuesday, November 9, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 15, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 8, 2022ASSIGNED TO EXAMINER
Wednesday, August 31, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 20, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 15, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 30, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, November 30, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, November 30, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 30, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 1, 2023SOU TEAS EXTENSION RECEIVED
Monday, May 1, 2023SOU EXTENSION 1 FILED
Monday, May 1, 2023SOU EXTENSION 1 GRANTED
Wednesday, May 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 30, 2023TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, May 8, 2024SOU EXTENSION 3 GRANTED
Monday, November 13, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 13, 2023SOU EXTENSION 2 FILED
Monday, November 13, 2023SOU EXTENSION 2 GRANTED
Wednesday, November 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 8, 2024SOU EXTENSION 3 FILED
Wednesday, May 8, 2024SOU TEAS EXTENSION RECEIVED
Thursday, May 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 25, 2024SOU TEAS EXTENSION RECEIVED
Friday, October 25, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 25, 2024SOU EXTENSION 4 GRANTED
Friday, October 25, 2024SOU EXTENSION 4 FILED

Related Keywords

voxvoka pharmaceutical treatment preparations cell disease sickle disorders blood thalassemia